Looking for a new broker?
Vivos Therapeutics, Inc. stock is up 533.58% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 3 December’s closed higher than November.
Vivos Therapeutics, Inc. develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada.
